Resources Investment Advisors Inc. now owns 1,170 shares of the medical research company's stock worth $132,000 after acquiring an additional 465 shares during the last quarter. The Hahn Capital Management Llc holds 1.15 million shares with $22.74 billion value, down from 1.16 million last quarter. The medical research company reported $0.75 EPS for the quarter, topping the consensus estimate of $0.72 by $0.03. The stock increased 4.06% or $0.75 during the last trading session, reaching $19.23. 1,668,774 shares of the company traded hands, compared to its average volume of 1,331,051. Cigna Corporation (NYSE:CI) has risen 13.35% since April 14, 2017 and is uptrending. It has outperformed by 20.43% the S&P500.
COPYRIGHT VIOLATION NOTICE: "Grandeur Peak Global Advisors LLC Acquires 775 Shares of Edwards Lifesciences Corp (EW)" was published by registrarjournal.com and is the property of of registrarjournal.com. The fund owned 15,050 shares of the medical research company's stock after buying an additional 775 shares during the period. And the reported value of the industrial specialties company is $100.68 million for the 2017Q4. The company has market cap of $29.02 billion. About 830,579 shares traded. EW reached $137.84 on during the last trading session after $1.44 change.Edwards Lifesciences Corporation is uptrending after having risen 44.06% since April 14, 2017. EW outperformed by 32.51% the S&P500.
Investors sentiment increased to 0.75 in Q4 2017. Its down 0.32, from 1.51 in 2017Q3.
Several large investors have recently bought and sold shares of the business. 141 funds opened positions while 552 raised stakes. Shares for $7.05M were sold by Cordani David. Shares for $1.34M were sold by MURABITO JOHN M. Ci Invests Incorporated holds 6.80 million shares. Covington Cap Mngmt accumulated 113,341 shares. Sentinel Tru Lba reported 17,090 shares. Moreover, Teachers Retirement System Of The State Of Kentucky has 0.21% invested in Cigna Corporation (NYSE:CI) for 89,732 shares. (NYSE:V) for 76,752 shares. Tokio Marine Asset reported 1,618 shares or 0.05% of all its holdings. 198,132 are owned by Lmr Prtnrs Limited Liability Partnership. 7,653 were accumulated by Co Bank. Stonebridge Capital Mngmt Inc holds 0.22% or 10,051 shares in its portfolio. Lipe & Dalton stated it has 1.14% in Visa Inc.
Since December 18, 2017, it had 0 insider buys, and 1 insider sale for $1.23 million activity. Biggar Lynne sold $205,440 worth of stock. It also reduced its holding in Abbvie Inc.
Analysts await Host Hotels & Resorts, Inc. Deutsche Bank has "Hold" rating and $115 target. Therefore 79% are positive. As per Friday, February 2, the company rating was maintained by Barclays Capital. The stock rating was maintained by Cowen & Co with "Buy" on Thursday, February 1. The stock of Visa Inc. The stock has "Buy" rating by RBC Capital Markets on Sunday, November 5. The company rating was maintained by Barclays Capital on Wednesday, October 25.
In reviewing some key ratios and quant data for Edwards Lifesciences Corporation (NYSE:EW), we note that the mother of all ratios (Return on Equity) stands at 0.197416 for the firm. On Monday, April 4 the stock rating was maintained by Jefferies with "Buy". Guggenheim initiated Visa Inc. The firm has "Buy" rating by SunTrust given on Thursday, January 21. Guggenheim has "Buy" rating and $85 target. During the same quarter last year, the business posted $0.75 earnings per share. analysts anticipate that Edwards Lifesciences Corp will post 4.53 EPS for the current fiscal year. EW's profit would be $231.57M giving it 31.33 P/E if the $1.10 EPS is correct.
Partner Investment Management Lp, which manages about $86.81 million US Long portfolio, upped its stake in Puma Biotechnology Inc (NYSE:PBYI) by 5,075 shares to 26,369 shares, valued at $2.61M in 2017Q4, according to the filing.
Grandeur Peak Global Advisors LLC grew its stake in Edwards Lifesciences Corp (NYSE:EW) by 5.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). Therefore 73% are positive. The stock has "Outperform" rating by William Blair on Monday, August 28. (NYSE:HST) to report earnings on April, 27. On Thursday, February 1 Stifel Nicolaus maintained Edwards Lifesciences Corporation (NYSE:EW) rating.
In other Edwards Lifesciences Corporation news, VP Larry L. Wood sold 13,258 shares of the firm's stock in a transaction that occurred on Thursday, December 1st. The stock of Edwards Lifesciences Corporation (NYSE:EW) earned "Buy" rating by Jefferies on Thursday, June 29. The firm has "Buy" rating by Robert W. Baird given on Friday, January 12. The firm earned "Hold" rating on Thursday, January 4 by Susquehanna. Zacks downgraded Edwards Lifesciences Corporation (NYSE:EW) on Tuesday, September 22 to "Hold" rating. The stock has "Outperform" rating by Cowen & Co on Friday, October 9. The stock of Chemical Financial Corporation (NASDAQ:CHFC) earned "Buy" rating by Stephens on Tuesday, July 25.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.